FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Complete Response on Adamis High-Dose Naloxone

[ Price : $8.95]

FDA issues Adamis Pharmaceuticals a complete response letter on its NDA for Adamis ZimHi (naloxone) high-dose injection for treati...

OPDP Hits Triferic Web Page Promotion

[ Price : $8.95]

CDER Office of Prescription Drug Promotion sends Rockwell Medical an untitled letter after reviewing the companys Triferic Web pag...

Draft Guide on Certificates of Confidentiality

[ Price : $8.95]

Federal Register notice: FDA has made available a draft guidance entitled Certificates of Confidentiality; Guidance for Sponsors, ...

Info Collection on FOIA Identity Form

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for Certification of Identity; Form FDA 3975.

Info Collection for Device Shortage Data System

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection for Medical Devices; Shortages Data Collection System.

Justice Hits Foundation Conspiracy with Drug Firms

[ Price : $8.95]

The U.S. Justice Department announces that a Florida foundation has agreed to pay $4 million to resolve allegations that it violat...

CBER Raps RichSource for Cell Therapy Claims

[ Price : $8.95]

CBER Office of Compliance and Biologics Quality issues RichSource Stem Cells an untitled letter over promotional statements on its...

Info Collection Revision on Biosimilar Program

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for General Licensing Provisions; Section 351(k...

Endo BLA Accepted for Cellulite Therapy

[ Price : $8.95]

FDA accepts for review an Endo International BLA for collagenase clostridium histolyticum (CCH) for treating cellulite in the butt...

Trump Extends FDA, Other Funding for 30 Days

[ Price : $8.95]

President Trump signs a short-term continuing resolution that funds FDA and other agencies at FY 2019 funding rates through 12/20.